ARUN POL: Open Payments
NPI 1205015534 · DULUTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,542 in 88 payments from 16 companies in 2025. Trend: 2023 $26,396 · 2024 $21,033 · 2025 $17,542
Honoraria: $13,375Food & beverage: $2,597Travel & lodging: $1,570
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 42 | $16,103 |
| Tris Pharma Inc | 8 | $345 |
| Janssen Pharmaceuticals, Inc | 5 | $219 |
| ABBVIE INC. | 5 | $202 |
| Axsome Therapeutics, Inc. | 5 | $171 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $111 |
| E.R. Squibb & Sons, L.L.C. | 1 | $105 |
| Vanda Pharmaceuticals Inc. | 5 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Neos Therapeutics, LP | 2 | $32 |
Products named: Qelbree, Dyanavel XR, SPRAVATO, VRAYLAR, Auvelity, TRINTELLIX, COBENFY, HETLIOZ.
Industry payments across GA — which companies pay providers there.
